NCT03744585View on ClinicalTrials.gov

Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

June 7, 2019

Study Completion Date

July 7, 2019

Conditions
Renal Cell Carcinoma
Trial Locations (1)

Unknown

Ipsen Central Contact, Paris

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT03744585 - Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts. | Biotech Hunter | Biotech Hunter